It’s only fair to share… Linvemastat CAS 2389060-50-6 MF C20H17N3O4S MW395.43 5-[3-[4-[(2-methyl-4-pyridinyl)methoxy]phenyl]sulfanylfuran-2-yl]imidazolidine-2,4-dione matrix metalloproteinase-12 inhibitor, lung diseases, FP 020, FP2AMM4SVF Linvemastat (also known by its developmental code FP-020) is an investigational, orally active small-molecule drug designed to selectively inhibit matrix metalloproteinase-12 (MMP-12). It is being developed as a potential disease-modifying therapy for chronic inflammatory and …